Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham J Mann

Showing results (101-110 of 183) with videos related to

Pageof 19
Sort By:
Genes, Chromosomes & Cancer|January 18, 2012
Identification of TFG (TRK-fused gene) as a putative metastatic melanoma tumor suppressor geneKen Dutton-Regester, Lauren G Aoude, Derek J Nancarrow, et al.
JAMA Dermatology|June 9, 2016
Development and External Validation of a Melanoma Risk Prediction Model Based on Self-assessed Risk FactorsKylie Vuong, Bruce K Armstrong, Elisabete Weiderpass, et al.
American Journal of Epidemiology|November 6, 2009
Population-based, case-control-family design to investigate genetic and environmental influences on melanoma risk: Australian Melanoma Family StudyAnne E Cust, Helen Schmid, Judith A Maskiell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2013
BRAF/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damageVictoria J Mar, Stephen Q Wong, Jason Li, et al.
Pigment Cell & Melanoma Research|July 30, 2013
Melanomas of unknown primary have a mutation profile consistent with cutaneous sun-exposed melanomaKen Dutton-Regester, Hojabr Kakavand, Lauren G Aoude, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 6, 2016
A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the PublicAmelia K Smit, David Espinoza, Ainsley J Newson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2020
Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia NomogramSerigne N Lo, Jiawen Ma, Richard A Scolyer, et al.
Journal of the National Cancer Institute|June 20, 2002
Geographical variation in the penetrance of CDKN2A mutations for melanomaD Timothy Bishop, Florence Demenais, Alisa M Goldstein, et al.
Oncotarget|October 22, 2014
TRIM16 inhibits proliferation and migration through regulation of interferon beta 1 in melanoma cellsSelina K Sutton, Jessica Koach, Owen Tan, et al.
The Journal of Investigative Dermatology|August 31, 2012
BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanomaGraham J Mann, Gulietta M Pupo, Anna E Campain, et al.
Pageof 19

Showing results (101-110 of 183) with videos related to

Sort By:
Pageof 19
Genes, Chromosomes & Cancer|January 18, 2012
Identification of TFG (TRK-fused gene) as a putative metastatic melanoma tumor suppressor geneKen Dutton-Regester, Lauren G Aoude, Derek J Nancarrow, et al.
JAMA Dermatology|June 9, 2016
Development and External Validation of a Melanoma Risk Prediction Model Based on Self-assessed Risk FactorsKylie Vuong, Bruce K Armstrong, Elisabete Weiderpass, et al.
American Journal of Epidemiology|November 6, 2009
Population-based, case-control-family design to investigate genetic and environmental influences on melanoma risk: Australian Melanoma Family StudyAnne E Cust, Helen Schmid, Judith A Maskiell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2013
BRAF/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damageVictoria J Mar, Stephen Q Wong, Jason Li, et al.
Pigment Cell & Melanoma Research|July 30, 2013
Melanomas of unknown primary have a mutation profile consistent with cutaneous sun-exposed melanomaKen Dutton-Regester, Hojabr Kakavand, Lauren G Aoude, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 6, 2016
A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the PublicAmelia K Smit, David Espinoza, Ainsley J Newson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2020
Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia NomogramSerigne N Lo, Jiawen Ma, Richard A Scolyer, et al.
Journal of the National Cancer Institute|June 20, 2002
Geographical variation in the penetrance of CDKN2A mutations for melanomaD Timothy Bishop, Florence Demenais, Alisa M Goldstein, et al.
Oncotarget|October 22, 2014
TRIM16 inhibits proliferation and migration through regulation of interferon beta 1 in melanoma cellsSelina K Sutton, Jessica Koach, Owen Tan, et al.
The Journal of Investigative Dermatology|August 31, 2012
BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanomaGraham J Mann, Gulietta M Pupo, Anna E Campain, et al.
Pageof 19